360 related articles for article (PubMed ID: 16285894)
61. Dendritic cell-based immunotherapy of malignant melanoma: success and limitations.
Tuettenberg A; Schmitt E; Knop J; Jonuleit H
J Dtsch Dermatol Ges; 2007 Mar; 5(3):190-6. PubMed ID: 17338793
[TBL] [Abstract][Full Text] [Related]
62. Dendritic cell vaccination for cancer therapy.
Nestle FO
Oncogene; 2000 Dec; 19(56):6673-9. PubMed ID: 11426654
[TBL] [Abstract][Full Text] [Related]
63. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
[TBL] [Abstract][Full Text] [Related]
64. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
[TBL] [Abstract][Full Text] [Related]
65. [Dendritic cells and their use in the therapy of neoplastic diseases].
Pospísilová D; Zavacká A; Hrusák O; Sedivá A; Spísek R; Bartůnková J
Cas Lek Cesk; 2000 Aug; 139(17):519-23. PubMed ID: 11109283
[TBL] [Abstract][Full Text] [Related]
66. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
Rossowska J; Pajtasz-Piasecka E
Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
[TBL] [Abstract][Full Text] [Related]
67. Dendritic cell migration to peripheral lymph nodes.
Martín-Fontecha A; Lanzavecchia A; Sallusto F
Handb Exp Pharmacol; 2009; (188):31-49. PubMed ID: 19031020
[TBL] [Abstract][Full Text] [Related]
68. Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts.
Mohty M; Olive D; Gaugler B
Leukemia; 2002 Nov; 16(11):2197-204. PubMed ID: 12399962
[TBL] [Abstract][Full Text] [Related]
69. Presentation of tumor antigens.
Hart DN; Schultze JL; Stewart AK
Semin Hematol; 1999 Jan; 36(1 Suppl 3):21-5. PubMed ID: 9989485
[TBL] [Abstract][Full Text] [Related]
70. Cancer immunotherapy by fusions of dendritic cells and tumor cells.
Koido S; Hara E; Homma S; Ohkusa T; Gong J; Tajiri H
Immunotherapy; 2009 Jan; 1(1):49-62. PubMed ID: 20635973
[TBL] [Abstract][Full Text] [Related]
71. [Tumor samples as a tool for large-scale monitoring of antigen-specific lymphocytes in gastric and colorectal neoplasms].
Matera L; Galetto A; Contarini M; Sapino A; Consalvo M; Cassoni P; Moro F; Mussa B; Mussa A
Chir Ital; 1999; 51(6):421-7. PubMed ID: 10742891
[TBL] [Abstract][Full Text] [Related]
72. Dendritic cells and autoimmunity.
Bayry J; Thirion M; Delignat S; Misra N; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Autoimmun Rev; 2004 Mar; 3(3):183-7. PubMed ID: 15110229
[TBL] [Abstract][Full Text] [Related]
73. Tumors and the danger model.
Kowalczyk DW
Acta Biochim Pol; 2002; 49(2):295-302. PubMed ID: 12362970
[TBL] [Abstract][Full Text] [Related]
74. Genetic modification of dendritic cells and its application for cancer immunotherapy.
Nishioka Y; Hua W; Nishimura N; Sone S
J Med Invest; 2002 Feb; 49(1-2):7-17. PubMed ID: 11901764
[TBL] [Abstract][Full Text] [Related]
75. Tumor immunity and immunotherapy.
Boura P; Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2001; 48(40):1040-4. PubMed ID: 11490795
[TBL] [Abstract][Full Text] [Related]
76. Current issues in dendritic cell cancer immunotherapy.
López JA; Hart DN
Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
[TBL] [Abstract][Full Text] [Related]
77. Cellular vaccine therapy for cancer.
Armstrong AC; Eaton D; Ewing JC
Expert Rev Vaccines; 2002 Oct; 1(3):303-16. PubMed ID: 12901571
[TBL] [Abstract][Full Text] [Related]
78. Dendritic cells in cancer immunotherapy - a short review.
Wojas K; Tabarkiewicz J; Roliński J
Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109
[TBL] [Abstract][Full Text] [Related]
79. Dendritic cell-mediated immunization in macroglobulinemia.
Dhodapkar MV
Semin Oncol; 2003 Apr; 30(2):305-8. PubMed ID: 12720158
[TBL] [Abstract][Full Text] [Related]
80. Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination.
John J; Dalgleish A; Melcher A; Pandha H
J Immunol Methods; 2005 Apr; 299(1-2):37-46. PubMed ID: 15890354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
